Cancer drugs
Modified on Fri, Mar 10, 2023 at 1:41 PM
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Paclitaxel | Taxane | Breast cancer, lung cancer | Injection | Neutropenia, neuropathy, and myalgia | D |
Cyclophosphamide | Alkylating Agent | Breast cancer and lymphoma | Oral, Injection | Neutropenia, alopecia, and cystitis | D |
Doxorubicin | Anthracycline | Breast cancer and lymphoma | Injection | Cardiotoxicity, alopecia, nausea | D |
5-Fluorouracil (5-FU) | Antimetabolite | Colorectal cancer, breast cancer | Injection, Topical | Myelosuppression, mucositis, and photosensitivity | D |
Imatinib | Tyrosine kinase inhibitor | Chronic myeloid leukemia, gastrointestinal stromal tumor | Oral | Edema, fatigue, diarrhea | D |
Rituximab | Monoclonal Antibody | Non-Hodgkin lymphoma, chronic lymphocytic leukemia | Injection | Infusion reactions, infections, hypotension | C |
Tamoxifen | Selective Estrogen Receptor Modulator (SERM) | Breast cancer | Oral | Hot flashes, vaginal discharge, and thromboembolism | D |
Cisplatin | Platinum-Based Chemotherapy | Testicular cancer, ovarian cancer | Injection | Nephrotoxicity, ototoxicity, and neuropathy | D |
Methotrexate | Antimetabolite | Leukemia, lymphoma | Oral, Injection | myelosuppression, mucositis, liver toxicity | X |
Trastuzumab | Monoclonal Antibody | Breast cancer, stomach cancer | Injection | Cardiotoxicity, infusion reactions, and diarrhea | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Bevacizumab | Monoclonal Antibody | Colorectal cancer, lung cancer | Injection | Hypertension, bleeding, and gastrointestinal perforation | D |
Erlotinib | Tyrosine kinase inhibitor | Lung cancer, pancreatic cancer | Oral | Rash, diarrhea, and nausea | D |
Vinblastine | Vinca Alkaloid | Hodgkin lymphoma, non-Hodgkin lymphoma | Injection | Myelosuppression, neuropathy, constipation | D |
Vincristine | Vinca Alkaloid | Hodgkin lymphoma, non-Hodgkin lymphoma | Injection | Myelosuppression, neuropathy, constipation | D |
Etoposide | Topoisomerase Inhibitor | Lung cancer, testicular cancer | Oral, Injection | Myelosuppression, nausea, and hair loss | D |
Carboplatin | Platinum-Based Chemotherapy | Lung cancer, ovarian cancer | Injection | Myelosuppression, nephrotoxicity, and neuropathy | D |
Docetaxel | Taxane | Breast cancer, prostate cancer | Injection | Neutropenia, neuropathy, and myalgia | D |
Doxil (doxorubicin hydrochloride liposome injection) | Anthracycline | Breast cancer, ovarian cancer | Injection | Cardiotoxicity, alopecia, nausea | D |
Gemcitabine | Antimetabolite | Pancreatic cancer, lung cancer | Injection | myelosuppression, nausea, and rash | D |
Bleomycin | Antibiotic | Hodgkin lymphoma, testicular cancer | Injection | Pulmonary toxicity, fever, and chills | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Pembrolizumab | Immune Checkpoint Inhibitor | Melanoma, non-small cell lung cancer | Injection | Fatigue, cough, rash | D |
Ipilimumab | Immune Checkpoint Inhibitor | Melanoma | Injection | Diarrhea, fatigue, and colitis | C |
Atezolizumab | Immune Checkpoint Inhibitor | Bladder cancer, lung cancer | Injection | Fatigue, cough, rash | D |
Brentuximab Vedotin | Antibody-Drug Conjugate | Hodgkin lymphoma, non-Hodgkin lymphoma | Injection | Peripheral neuropathy, fatigue, and nausea | D |
Trametinib | Mitogen-Activated Protein Kinase (MAPK) Inhibitor | Melanoma, non-small cell lung cancer | Oral | Rash, diarrhea, and fatigue | D |
Vemurafenib | BRAF Inhibitor | Melanoma | Oral | Rash, arthralgia, and fatigue | D |
Nivolumab | Immune Checkpoint Inhibitor | Melanoma, non-small cell lung cancer | Injection | Fatigue, cough, rash | D |
Dasatinib | Tyrosine kinase inhibitor | Leukemia | Oral | Myelosuppression, fluid retention, diarrhea | D |
Temozolomide | Alkylating Agent | Brain tumors | Oral | Myelosuppression, nausea, fatigue | D |
Cetuximab | Monoclonal Antibody | Colorectal cancer, head and neck cancer | Injection | Acneiform rash, hypomagnesemia, infusion reactions | C |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
L-asparaginase | Enzyme | Acute lymphoblastic leukemia | Injection | Hypersensitivity reactions, myelosuppression, and pancreatitis | C |
Fludarabine | Antimetabolite | Chronic lymphocytic leukemia | Oral, Injection | Myelosuppression, fever, cough | D |
Interferon alfa-2a | Interferon | Melanoma, chronic myeloid leukemia | Injection | Flu-like symptoms, depression, neutropenia | C |
Methoxsalen | Psoralen | Cutaneous T-cell lymphoma | Oral | Nausea, dizziness, and skin photosensitivity | C |
Mitoxantrone | Anthracenedione | Acute myeloid leukemia, prostate cancer | Injection | myelosuppression, cardiotoxicity, nausea | D |
Oxaliplatin | Platinum-Based Chemotherapy | Colorectal cancer | Injection | Neuropathy, myelosuppression, and nausea | D |
Palbociclib | Cyclin-Dependent Kinase (CDK) Inhibitor | Breast cancer | Oral | Neutropenia, fatigue, and nausea | D |
Sorafenib | Tyrosine kinase inhibitor | Renal cell carcinoma, hepatocellular carcinoma | Oral | Hand-foot syndrome, diarrhea, and hypertension | D |
Topotecan | Topoisomerase Inhibitor | Ovarian cancer, small cell lung cancer | Oral, Injection | myelosuppression, nausea, vomiting | D |
Vincristine Sulfate Liposome Injection | Vinca Alkaloid | Acute lymphoblastic leukemia | Injection | Peripheral neuropathy, constipation, and nausea | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Lenalidomide | Immunomodulatory Agent | Multiple myeloma | Oral | Fatigue, nausea, and myelosuppression | X |
Abiraterone | androgen synthesis inhibitor | Prostate cancer | Oral | Hypertension, hypokalemia, fatigue | X |
Daratumumab | Monoclonal Antibody | Multiple myeloma | Injection | Infusion reactions, myelosuppression, fatigue | D |
Ibrutinib | Bruton's Tyrosine Kinase Inhibitor | Chronic lymphocytic leukemia, mantle cell lymphoma | Oral | Bleeding, diarrhea, and myelosuppression | D |
Cabazitaxel | Taxane | Prostate cancer | Injection | Neutropenia, anemia, fatigue | D |
Venetoclax | B-cell lymphoma 2 (BCL-2) inhibitor | Chronic lymphocytic leukemia | Oral | Neutropenia, diarrhea, and nausea | D |
Osimertinib | Epidermal Growth Factor Receptor (EGFR) Inhibitor | Non-small cell lung cancer | Oral | diarrhea, rash, myelosuppression | D |
Tisagenlecleucel | Chimeric antigen receptor (CAR) T-cell therapy | B-cell acute lymphoblastic leukemia | Intravenous Infusion | Cytokine release syndrome, neurological toxicity, infection | D |
Pertuzumab | Monoclonal Antibody | Breast cancer | Injection | Diarrhea, nausea, and neutropenia | D |
Romidepsin | Histone deacetylase (HDAC) inhibitor | Cutaneous T-cell lymphoma | Injection | Fatigue, nausea, and myelosuppression | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Everolimus | mammalian target of rapamycin (mTOR) inhibitor | Breast cancer, pancreatic cancer | Oral | Fatigue, rash, and nausea | D |
Alectinib | Anaplastic Lymphoma Kinase (ALK) Inhibitor | Non-small cell lung cancer | Oral | Edema, constipation, and myelosuppression | D |
Sipuleucel-T | Autologous Cellular Immunotherapy | Prostate cancer | Intravenous Infusion | Infusion reactions, chills, fever | C |
Pembrolizumab | Immune Checkpoint Inhibitor | Head and neck cancer, melanoma | Injection | Fatigue, cough, rash | D |
Trastuzumab Emtansine | Antibody-Drug Conjugate | Breast cancer | Injection | Peripheral neuropathy, fatigue, and nausea | D |
Enzalutamide | androgen receptor antagonist | Prostate cancer | Oral | Fatigue, hypertension, and myelosuppression | X |
Brentuximab Vedotin | Monoclonal Antibody | Hodgkin lymphoma, non-Hodgkin lymphoma | Injection | Peripheral neuropathy, fatigue, and nausea | D |
Mitomycin C | Antibiotic | Bladder cancer, gastric cancer | Injection | myelosuppression, nausea, vomiting | D |
Necitumumab | Monoclonal Antibody | Non-small cell lung cancer | Injection | Rash, hypomagnesemia, and nausea | C |
Olaparib | Poly(ADP-ribose) polymerase (PARP) inhibitor | Ovarian cancer | Oral | Myelosuppression, nausea, fatigue | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Temozolomide | Alkylating Agent | Brain tumors | Oral | Myelosuppression, nausea, fatigue | D |
Trametinib | Mitogen-Activated Protein Kinase (MAPK) Inhibitor | Melanoma, non-small cell lung cancer | Oral | Rash, diarrhea, and fatigue | D |
Vemurafenib | BRAF Inhibitor | Melanoma | Oral | Rash, arthralgia, and fatigue | D |
Nivolumab | Immune Checkpoint Inhibitor | Melanoma, non-small cell lung cancer | Injection | Fatigue, cough, rash | D |
Dasatinib | Tyrosine kinase inhibitor | Leukemia | Oral | Myelosuppression, fluid retention, diarrhea | D |
Carboplatin | Platinum-Based Chemotherapy | Lung cancer, ovarian cancer | Injection | Myelosuppression, nephrotoxicity, and neuropathy | D |
Docetaxel | Taxane | Breast cancer, prostate cancer | Injection | Neutropenia, neuropathy, and myalgia | D |
Doxil (doxorubicin hydrochloride liposome injection) | Anthracycline | Breast cancer, ovarian cancer | Injection | Cardiotoxicity, alopecia, nausea | D |
Gemcitabine | Antimetabolite | Pancreatic cancer, lung cancer | Injection | myelosuppression, nausea, and rash | D |
Bleomycin | Antibiotic | Hodgkin lymphoma, testicular cancer | Injection | Pulmonary toxicity, fever, and chills | D |
Cisplatin | Platinum-Based Chemotherapy | Bladder cancer, testicular cancer | Injection | Nephrotoxicity, myelosuppression, and neuropathy | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Rituximab | Monoclonal Antibody | Non-Hodgkin lymphoma, chronic lymphocytic leukemia | Injection | Infusion reactions, myelosuppression, fever | C |
Ixabepilone | Epothilone | Breast cancer | Injection | Neuropathy, myelosuppression, fatigue | D |
Idelalisib | Phosphoinositide 3-Kinase (PI3K) Inhibitor | Chronic lymphocytic leukemia | Oral | diarrhea, rash, liver toxicity | D |
Folfirinox (5-FU, leucovorin, irinotecan, oxaliplatin) | Chemotherapy Combination | Pancreatic cancer | Intravenous Infusion | Myelosuppression, diarrhea, neuropathy | D |
Cyclophosphamide | Alkylating Agent | Breast cancer, ovarian cancer | Oral, Injection | myelosuppression, nausea, vomiting | D |
Cetuximab | Monoclonal Antibody | Colorectal cancer, head and neck cancer | Injection | Acneiform rash, hypomagnesemia, infusion reactions | C |
Fluorouracil (5-FU) | Antimetabolite | Colorectal cancer, breast cancer | Injection, topical, or oral | Myelosuppression, nausea, mucositis | D |
Goserelin | Gonadotropin-Releasing Hormone (GnRH) Agonist | Breast cancer, prostate cancer | Injection | Hot flashes, decreased libido, and bone loss | D |
Lenograstim | Granulocyte Colony-Stimulating Factor (G-CSF) | Chemotherapy-Induced Neutropenia | Injection | Bone pain, fever, and headache | C |
Mitoxantrone | Anthracenedione | Acute myeloid leukemia, prostate cancer | Injection | myelosuppression, cardiotoxicity, nausea | D |
Drug Name | Drug Class | Indication | Route of Administration | Side Effects | Pregnancy Category |
Ado-trastuzumab emtansine | Antibody-Drug Conjugate | Breast cancer | Injection | Fatigue, nausea, and peripheral neuropathy | D |
Atezolizumab | Immune Checkpoint Inhibitor | Non-small cell lung cancer, bladder cancer | Injection | Fatigue, cough, and fever | D |
Bortezomib | Proteasome Inhibitor | Multiple myeloma | Injection | Peripheral neuropathy, nausea, and diarrhea | D |
Cabozantinib | Tyrosine kinase inhibitor | Kidney cancer, thyroid cancer | Oral | Diarrhea, fatigue, and hand-foot syndrome | D |
Lenalidomide | Immunomodulatory Agent | Multiple myeloma | Oral | Fatigue, myelosuppression, diarrhea | X |
Radium-223 dichloride | Radioactive Agent | Prostate cancer | Injection | Myelosuppression, nausea, and diarrhea | X |
Regorafenib | Tyrosine kinase inhibitor | Colorectal cancer, gastrointestinal stromal tumor | Oral | Fatigue, hand-foot syndrome, hypertension | D |
Venetoclax | B-cell lymphoma 2 (BCL-2) inhibitor | Chronic lymphocytic leukemia | Oral | Myelosuppression, nausea, and diarrhea | D |
Zoledronic acid | Bisphosphonate | Bone metastases, multiple myeloma | Injection | Bone pain, fever, and flu-like symptoms | D |
Temsirolimus | mammalian target of rapamycin (mTOR) inhibitor | Kidney cancer | Injection | Hyperglycemia, rash, fatigue | X |
Please be aware that there are numerous additional cancer medications and treatments available, and this list is not all-inclusive. Additionally, because they are subject to change as new research becomes available, the categories for side effects and pregnancy listed here may not be current.
Was this article helpful?
That’s Great!
Thank you for your feedback
Sorry! We couldn't be helpful
Thank you for your feedback
Feedback sent
We appreciate your effort and will try to fix the article